Well Test News Today

Hunting plc 15.3% potential upside indicated by Jefferies

Global offshore decommissioning work continues at pace, with a significant portion occurring on the UKCS. Meanwhile, technical advances related to decommissioning continue, as well.

The multi-year decommissioning contract, valued at more than $20 million, will utilize Expro’s Subsea Well Access technology with a combination of open-water and in-riser applications deployed from a semi-submersible rig.

Offshore well services firm Expro said Monday it had won a new contract with oil and gas company Harbour Energy for a well…

Energy services provider Expro has secured a new contract with Harbour Energy for a well abandonment campaign as part of the decommissioning project for the Balmoral area, in the UK Continental Shelf.

Innovative subsea intervention solution helps secure Plug Abandonment contract Energy services provider Expro (NYSE: XPRO) has secured a new contract with Harbour Energy for a well abandonment campaign

Revenue of $339 million, down 3% sequentially and up 21% year-over-year Adjusted EBITDA1 of $42 million , down 40% sequentially and up 14% year-over-year. Excluding such LWI-related costs, Adjusted... | May 4, 2023

Expro Group Holdings N.V. (NYSE:NYSE:XPRO) Q2 2022 Earnings Conference Call August 04, 2022 11:00 AM ET Company Participants Karen David-Green - Chief Communication, Stakeholder &...

A Japanese university research team says it has concluded that the worlds first clinical trial, spanning over years, transplanting corneal tissues derived from induced pluripotent stem cells, or iPS cells, into four almost-blind patients was safe and effective.

Keio University in Tokyo says it has started the worlds first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.